| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 0.710 | 20130111, Ott H
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Brazil | IgE | 11 | 90.900 | 20130429, Bueno de Sa A
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 3.030 | 20110223, De Knop KJ
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | France | IgE | 97 | 24.000 | 20120706, Garnier L
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.000 | 20120528, Patelis A
| | 6.5 - Occupational Exposure | 2012 | South Africa | IgE | 85 | 0.000 | 20120404, Singh T
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Taiwan | IgE | 12 | 91.660 | 20110119, Lee MF
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 5.813 | 20101214, Gadisseur R
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 0.340 | 20100301, Scala E
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Germany | IgE | 52 | 23.070 | 20100423, Ott H
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 101 | 2.970 | 20101118, Bublin M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 48 | 2.080 | 20101118, Bublin M
| | 1.1 - Asymptomatic | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 5.000 | 20091005, Ott H
| | 3.2.1 - Source Sensitized (IgE) | 2009 | Belgium | BPT | 20 | 0.000 | 20091121, Ebo DG
| | 3.2.1 - Source Sensitized (IgE) | 2009 | Italy | IgE | 7 | 0.000 | 20091030, Quercia O
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 2.702 | 20090826, Ebo DG
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 18.180 | 20091121, Ebo DG
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Japan | IgE | 14 | 0.000 | 20090520, Yagami A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Japan | SPT | 14 | 0.000 | 20090520, Yagami A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Portugal | IgE | 5 | 0.000 | 20080904, Rodrigues Alves R
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2006 | Spain | IgE | 23 | 13.000 | 20060324, Sanz ML
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2005 | Spain | IgE | 31 | 54.800 | | | 3.1.2 - Source Sensitized - High Exposure (SPT) | 2003 | United States | SPT | 62 | 23.000 | | | 3.1.4 - Source Sensitized (SPT, IgE) | 2001 | Germany | IgE | 15 | 46.700 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2001 | Germany | IgE | 38 | 81.600 | | | 5.1.1 - Source Exposed (Symptoms) | 2000 | United States | IgE | 44 | 52.300 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2000 | Finland | IgE | 8 | 13.000 | 2000, Yeang HY
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2000 | United States | IgE | 28 | 0.000 | 2000, Yeang HY
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 1998 | Finland | IgE | 42 | 38.100 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 1997 | Germany | IgE | 105 | 52.400 | | | 6.6 - Source Exposure | 1997 | Germany | IgE | 140 | 40.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Finland | IgE | 45 | 17.800 | | | 6.6 - Source Exposure | 1995 | United States | IgE | 17 | 76.500 | |
|
Loading...
Hev b 1
